A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg) in postmenarcheal adolescents
Gemzell-Danielsson, Kristina, Buhling, Kai J, Dermout, Sylvia M, Lukkari-Lax, Eeva, Montegriffo, Elaine, Apter, Dan
Published in Contraception (Stoneham) (01.06.2016)
Published in Contraception (Stoneham) (01.06.2016)
Get full text
Journal Article